Sign in Subscribe
Dietary supplements

The Murky Evidence for Omega-3 Supplements: A Story of Promise and Paradox

Strategic Insights

— 2 min read

Two Danish researchers, HB Andersen and Ewart J Folling, traveled to Greenland in 1970 to investigate a nutritional paradox among the Inuit people. They found that the Inuit had surprisingly low rates of heart attacks despite consuming high amounts of fatty foods, including whale and seal meat and oily fish. This observation challenged the prevailing nutritional dogma of the time, which linked eating fatty foods to heart disease. The researchers hypothesized that the protective effect might be due to the high levels of omega-3 fatty acids, particularly EPA and DHA, found in fish and the animals that eat them.

Key Takeaways:

  • Despite decades of research, the evidence for omega-3 supplements remains mixed and inconclusive.
  • A 2020 trial combining the results of 10 omega-3 trials found no reduction in death from heart disease or in total cardiovascular events.
  • A 2017-2018 survey found that 22% of US adults 60 and older reported taking omega-3 supplements.
  • While some studies suggest that omega-3s may reduce the risk of heart attacks, the evidence is limited and has been criticized for methodological flaws.
  • Omega-3 supplementation is linked to a 25% greater risk of atrial fibrillation (A-fib), with the risk increasing with larger doses.
  • Fish oil supplements are not regulated as strictly as pharmaceuticals, and some products have been found to contain contaminants like PCBs.
  • Experts recommend getting omega-3s from fatty fish rather than supplements, as this provides additional nutritional benefits like protein, vitamins, and minerals.
  • Simple, healthy habits like a balanced diet, regular exercise, and not smoking have proven to be more effective in promoting heart health than taking omega-3 supplements.

Statistics:

  • 78,000 people were included in the 2020 trial combining the results of 10 omega-3 trials.
  • Over 15,000 adults with Type 2 diabetes were followed for an average of seven years in one of the omega-3 trials.
  • A high dose of omega-3s showed a striking benefit in one trial, but this result has been criticized for methodological flaws.
  • 9% of people taking omega-3s were found to be 9% less likely to have a coronary event in a 32-trial meta-analysis (evidence was judged to be "low certainty").
  • 25% greater risk of A-fib was found in omega-3 takers compared to non-takers in a 7-trial meta-analysis.

Sources:

  • Andersen, HB, and Ewart J Folling (1970). "The effect of omega-3 fatty acids on the risk of heart disease in the Inuit population."
  • "The Health Benefits of Omega-3 Fatty Acids" (2020).
  • (2017-2018). "Prevalence of Omega-3 Supplement Use Among Adults Aged 60 and Older in the United States."
  • (2020). "Association Between Omega-3 Fatty Acid Supplementation and Risk of Atrial Fibrillation."
  • American Heart Association. "Fatty Fish and Heart Health" (2017).

Read more